MITF and melanoma: Acquisition of a low microphthalmia-associated factor MITF state together with activation of epithelial-mesenchymal transition (EMT) can transform melanoma cells to a highly invasive, dedifferentiated and therapy-resistant phenotype with cancer cell plasticity (Kemper et al. 2014).